Survey Overview

AI in Healthcare Market Intelligence

Sample size: 25 respondents

Survey Overview

Geography, roles, and focus area

25 Respondents
Sample size
25 respondents
Geography
United States (15), United Kingdom (10)
Roles
Market intelligence analysts, pharma strategists, healthcare consultants, data scientists
Focus
Impact of AI on healthcare market intelligence (MI)

Question-wise Response Analysis

Summary of responses from 25 participants

10 Questions

Responses:

Response Count Percentage
Very significant1664%
Moderately significant728%
Minimal impact28%

Outcome: AI is widely perceived as transformational, not incremental. Most respondents agree it is fundamentally reshaping workflows rather than just improving efficiency.

(Multiple selections allowed)

Responses:

Area Count Percentage
Competitive intelligence1872%
Forecasting & demand modeling1768%
Customer/patient insights1560%
Data collection & aggregation2080%
Reporting & visualization2080%

Outcome: The strongest impact is on data-heavy functions—especially aggregation and competitive tracking—where automation replaces manual effort.

Responses:

Benefit Count Percentage
Faster insights2184%
Improved data accuracy1456%
Ability to analyze unstructured data1976%
Cost reduction1144%
Better predictive capabilities1664%

Outcome: Speed and scale dominate. AI is valued most for processing large, complex datasets quickly, particularly unstructured sources like physician notes or publications.

Responses:

Challenge / Risk Count Percentage
Data privacy/regulatory concerns2080%
Lack of transparency (black-box models)1768%
Data quality issues1560%
Integration with legacy systems1352%
Skills gap1248%

Outcome: Concerns are heavily compliance-driven, especially in healthcare environments with strict regulatory frameworks (HIPAA/GDPR equivalents).

Responses:

Reliability Count Percentage
More reliable832%
Equally reliable1144%
Less reliable624%

Outcome: Trust is moderate but not absolute. Most respondents see AI as a complement, not a replacement, for human validation.

Responses:

Change Count Percentage
More strategic focus1872%
Less manual data work2184%
Need for new technical skills1664%
Role largely unchanged312%

Outcome: Roles are shifting toward interpretation and strategy, with less emphasis on data gathering.

Responses:

Adoption Level Count Percentage
Enterprise-wide936%
Department-level1040%
Pilot stage520%
No adoption14%

Outcome: Adoption is fragmented but progressing, with most organizations beyond experimentation.

Responses:

Technology Count Percentage
Machine learning models1976%
Natural language processing (NLP)1768%
Generative AI1352%
Robotic process automation (RPA)1144%

Outcome: Traditional AI (ML/NLP) still dominates, but generative AI is rapidly emerging.

Responses:

Data Source Count Percentage
Real-world evidence (RWE)1872%
Social media & patient forums1456%
Clinical trial data1664%
Sales & prescription data1560%

Outcome: AI is especially impactful in unlocking non-traditional and unstructured datasets.

Responses:

Expectation Count Percentage
Major transformation1768%
Incremental improvement624%
Uncertain28%

Outcome: Forward-looking sentiment is strongly positive, with expectations of deep integration into decision-making processes.

Key Cross-Cutting Insights

Main patterns across the survey

Automation → Augmentation
AI is reducing manual effort but not eliminating human roles. Instead, it’s enabling higher-level analytical work.
Data Explosion Handling
The biggest value lies in managing volume, velocity, and variety of healthcare data.
Trust Gap Still Exists
Despite benefits, concerns around explainability and regulation prevent full reliance.
Competitive Advantage Driver
Organizations adopting AI effectively see it as a differentiator in market strategy.
Skills Shift
Demand is rising for hybrid profiles combining: Domain expertise (healthcare), Analytical skills, AI/data literacy
Conclusion
Across US and UK respondents, AI is viewed as a high-impact enabler of faster, broader, and more predictive market intelligence in healthcare. However, its effectiveness depends on addressing regulatory, trust, and integration challenges.
Thought Leadership

Trusted by Industry Leaders

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.

SPER-Astellas Pharma
SPER-Microsoft
SPER-EY
SPER-McKinsey
SPER-Bain
SPER-Max-Healthcare
SPER-DHL
SPER-IQVIA
SPER-Mitsubishi Logistics
SPER-PACCOR
SPER-Macmillan Education
SPER-Kankar IMRB
SPER-ITA
SPER-PWC
SPER-SAPTCA
SPER-Straumann
SPER-Danaher
SPER-AandM
SPER-MENARINI Silicon Biosystems
SPER-IPSOS
SPER-Heineken
HIPPA Compliant
GDPR Certified
ISO 27001
Peer Reviewed
Get Started Today

Your Competitive Advantage in
Pharmaceutical & Medical Technology
Markets

Join industry leaders leveraging AI-powered intelligence to make confident, data-driven decisions that accelerate breakthrough treatments and technologies to market.

No Credit Card Required
15-Minute Demo
Expert Guidance